Buy Crypto
Markets
Spot
FuturesBTC
Earn
Event Center
Rewards Hub
More
100%+ PoR
JAZZ

Jazz Pharmaceuticals, Inc. (JAZZ)

NASDAQ
$247.47
+$6.99
(+2.90%)
Previous Close: ⁦$240.71⁩
Market Closed

Last updated: ⁦2026-11-19 02:53:40⁩. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.

Summary

Jazz Pharmaceuticals, Inc. (JAZZ) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $247.47, with a market capitalization of $15.39B and a P/E ratio of 75.02. Over the past 52 weeks, its price has ranged from $156.95 to $266.38. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

$15.39B

$240.34

$248.16

$236.95

$240.71

570.43K

884.80K

75.02

$266.38

$156.95

--

2026-09-30

Jazz Pharmaceuticals, Inc. (JAZZ) Latest Closing Stock Price

Jazz Pharmaceuticals, Inc. (JAZZ) last closed at $247.47 as of 2026-11-19 00:31:00, up 2.90% ($6.99) from the previous close of $240.71.

During the latest regular trading session, JAZZ traded between $236.95 and $248.16, with a volume of 570.43K shares. The closing price was near the upper end and near the upper end of its 52-week range.

Jazz Pharmaceuticals, Inc. (JAZZ) 7-Day Stock Price Change

Over the past seven days, Jazz Pharmaceuticals, Inc. (JAZZ) moved from $243.55 to $247.47, representing a gain of 1.61% ($3.93).

The stock traded between $235.14 and $249.99 during the period. The latest price is near the upper end of the 7-day range, indicating moderate upward.

The average daily volume was 589.50 thousand shares, down versus the previous seven-day period, indicating lower trading activity.

JAZZ 52-Week Price Position

Position in Range: 82.7%

52W Low$156.95
52W High$266.38

JAZZ is currently trading at $247.47, placing it 82.7% of the way from its 52-week low of $156.95 to its 52-week high of $266.38. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Jazz Pharmaceuticals, Inc. (JAZZ)?

Jazz Pharmaceuticals is an Ireland-domiciled biopharmaceutical firm focused primarily on treatments for sleeping disorders and oncology. Jazz has nine approved drugs across neuroscience and oncology indications; its portfolio includes Xyrem and Xywav for narcolepsy, Zepzelca for the treatment of metastatic small cell lung cancer, Rylaze for acute lymphoblastic leukemia, and Vyxeos for acute myeloid leukemia. In May 2021, Jazz acquired GW Pharmaceuticals and gained its leading product, Epidiolex for the treatment of severe, rare forms of epilepsy.

Jazz Pharmaceuticals, Inc. Information

Industry
PHARMACEUTICAL PREPARATIONS
Employees
2,890
Exchange
NASDAQ
Company Website

JAZZ News

Latest news related to Jazz Pharmaceuticals, Inc. and JAZZ stock.

  • Massive

    AASM releases roadmap to improve women’s sleep health

    The American Academy of Sleep Medicine released a comprehensive report and multiyear roadmap to improve women's sleep health, identifying priority areas including fertility, pregnancy, postpartum health, menopausal transitions, and sleep disorders. The report highlights gaps in research, clinical care, and policy, calling for increased clinical trial representation, research funding, and tailored interventions for women.

    Read Full Article
  • Benzinga

    CrowdStrike To Rally Around 21%? Here Are 10 Top Analyst Forecasts For Friday

    Analysts raised CrowdStrike and Jazz targets, while cutting targets for Cisco, Fermi, Twist Bioscience, Applied Materials, Firefly and Nebius.

    Read Full Article
  • Massive

    Brain Cancer Biotech Race Heats Up as NeOnc, Nuvation, Jazz and Cerenome Present New Data at SNO

    Four biotechnology companies presented clinical findings and emerging treatment approaches for brain cancers at the 31st Annual Meeting of the Society for Neuro-Oncology in Philadelphia. NeOnc Technologies is preparing for FDA meetings on two programs (NEO100 and NEO212), Cerenome is advancing REYOBIQ therapy and diagnostic tools, Nuvation Bio is expanding data on safusidenib for IDH1-mutant gliomas, and Jazz Pharmaceuticals is progressing dordaviprone through Phase 3 trials for rare brain cancers.

    Read Full Article
  • Benzinga

    Morgan Stanley Maintains Overweight on Jazz Pharmaceuticals, Raises Price Target to $324

    Morgan Stanley analyst Jeffrey Hung maintains Jazz Pharmaceuticals (NASDAQ:JAZZ) with a Overweight and raises the price target from $319 to $324.

    Read Full Article
  • Benzinga

    Piper Sandler Maintains Overweight on Jazz Pharmaceuticals, Raises Price Target to $330

    Piper Sandler analyst David Amsellem maintains Jazz Pharmaceuticals (NASDAQ:JAZZ) with a Overweight and raises the price target from $310 to $330.

    Read Full Article

Ways to Trade JAZZ at MEXC

JAZZ MEXC RealStocks

Own real JAZZ shares through MEXC's regulated brokerage partner.


Suitable for long-term holding.

  • Own the actual shares
  • Receive dividends and voting rights
  • Buy fractional shares starting at $1

How to Buy Jazz Pharmaceuticals, Inc. (JAZZ) Stock on MEXC

Eligible investors can buy real shares of Jazz Pharmaceuticals, Inc. (JAZZ) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account
Step 1: Open and Verify Your RealStocks Account
Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.
Step 2: Transfer USDT to Your RealStocks Account
Step 2: Transfer USDT to Your RealStocks Account
Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.
Step 3: Search for JAZZ and Place Your Order
Step 3: Search for JAZZ and Place Your Order
Open the RealStocks trading page and search for JAZZ. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Jazz Pharmaceuticals, Inc. (JAZZ) stock price today?
Jazz Pharmaceuticals, Inc. (JAZZ) is currently trading at $247.47, up 2.90% ($6.99) from the previous close of $240.71. Intraday prices update in real time during regular trading hours.
2.Is JAZZ stock going up or down today?
As of 2026-11-19 00:31:00, JAZZ is trading at $247.47, up 2.90% ($6.99) from its previous close of $240.71. The stock has traded between $236.95 and $248.16 during today’s regular session. Past price movements do not guarantee future results.
3.What is JAZZ pre-market price?
As of 2026-11-19 00:31:00, JAZZ is trading at $239.06 in pre-market trading, down 0.69% ($1.65) from the previous close of $240.71. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.
4.What is JAZZ after-hours price?
As of 2026-11-19 00:31:00, JAZZ is trading at $247.35 in after-hours trading, down 0.05% ($0.12) from the regular-session close of $247.47. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.
5.Is JAZZ stock trading now?
JAZZ trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.
6.Where does JAZZ sit relative to its 52-week high and low?
Over the past 52 weeks, JAZZ has traded between a low of $156.95 and a high of $266.38. At $247.47, the stock is positioned 82.7% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.
7.What sector is Jazz Pharmaceuticals, Inc. in?
Jazz Pharmaceuticals, Inc. (JAZZ) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.
8.What is Jazz Pharmaceuticals, Inc.'s market capitalization and where is it listed?
Jazz Pharmaceuticals, Inc. is listed on the NASDAQ exchange with a market capitalization of $15.39B. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.
9.How is JAZZ valued in terms of P/E ratio and EPS?
JAZZ trades at a P/E ratio of 75.02, based on trailing-twelve-month EPS of $3.21. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.
10.Does Jazz Pharmaceuticals, Inc. pay a dividend?
Jazz Pharmaceuticals, Inc. pays an indicated annual cash dividend of $0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.

Explore More US Stocks

Stocks in the Same Sector

Browse other US stocks in the same sector as Jazz Pharmaceuticals, Inc.

Largest Market Cap

See US stocks with the highest market capitalization

Most Actively Traded

Discover today's most actively traded US stocks

Top 5 Cryptocurrencies

Explore the cryptocurrencies with the highest market capitalization

Compliance Disclosure and Data Source

Stock prices and market data on this page, including price changes and market status, are provided by Massive and other third-party news and data platforms. Market data may be delayed and may differ from prices on other platforms or the prices at which trades are executed on MEXC. MEXC does not guarantee the accuracy, completeness, or timeliness of third-party data. MEXC offers trading products related to JAZZ, including Stocks, Tokenized Stocks, and Stock Futures.

Disclaimer

The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.

Search Stocks

JAZZ Stock Calculator

Estimate the value between JAZZ shares and USD.

JAZZ Shares to USD

JAZZ Shares
JAZZ
JAZZ
USD
USD
USD

1.00 JAZZ shares = 247.473 USD

Calculations are estimates based on the latest available price and are for reference only.